The periodic shedding of the ENDOMETRIUM and associated menstrual bleeding in the MENSTRUAL CYCLE of humans and primates. Menstruation is due to the decline in circulating PROGESTERONE, and occurs at the late LUTEAL PHASE when LUTEOLYSIS of the CORPUS LUTEUM takes place.
Variations of menstruation which may be indicative of disease.
The period from onset of one menstrual bleeding (MENSTRUATION) to the next in an ovulating woman or female primate. The menstrual cycle is regulated by endocrine interactions of the HYPOTHALAMUS; the PITUITARY GLAND; the ovaries; and the genital tract. The menstrual cycle is divided by OVULATION into two phases. Based on the endocrine status of the OVARY, there is a FOLLICULAR PHASE and a LUTEAL PHASE. Based on the response in the ENDOMETRIUM, the menstrual cycle is divided into a proliferative and a secretory phase.
Personal care items used during MENSTRUATION.
Painful menstruation.
The mucous membrane lining of the uterine cavity that is hormonally responsive during the MENSTRUAL CYCLE and PREGNANCY. The endometrium undergoes cyclic changes that characterize MENSTRUATION. After successful FERTILIZATION, it serves to sustain the developing embryo.
Absence of menstruation.
Chemical compounds that induce menstruation either through direct action on the reproductive organs or through indirect action by relieving another condition of which amenorrhea is a secondary result. (From Dorland, 27th ed)
Excessive uterine bleeding during MENSTRUATION.
A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum.
A combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse (such as pain, water-retention, anxiety, cravings, and depression) and they diminish markedly 2 or 3 days after the initiation of menses.
The first MENSTRUAL CYCLE marked by the initiation of MENSTRUATION.
The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS.
A synthetic progestational hormone used often in mixtures with estrogens as an oral contraceptive.
The period in the MENSTRUAL CYCLE that follows OVULATION, characterized by the development of CORPUS LUTEUM, increase in PROGESTERONE production by the OVARY and secretion by the glandular epithelium of the ENDOMETRIUM. The luteal phase begins with ovulation and ends with the onset of MENSTRUATION.
The hollow thick-walled muscular organ in the female PELVIS. It consists of the fundus (the body) which is the site of EMBRYO IMPLANTATION and FETAL DEVELOPMENT. Beyond the isthmus at the perineal end of fundus, is CERVIX UTERI (the neck) opening into VAGINA. Beyond the isthmi at the upper abdominal end of fundus, are the FALLOPIAN TUBES.
Abnormally infrequent menstruation.
A synthetic progestational hormone with no androgenic or estrogenic properties. Unlike many other progestational compounds, dydrogesterone produces no increase in temperature and does not inhibit OVULATION.
Bleeding from blood vessels in the UTERUS, sometimes manifested as vaginal bleeding.
Benzenesulfonate derivative used as a systemic hemostatic.
The period of the MENSTRUAL CYCLE representing follicular growth, increase in ovarian estrogen (ESTROGENS) production, and epithelial proliferation of the ENDOMETRIUM. Follicular phase begins with the onset of MENSTRUATION and ends with OVULATION.
A butyrophenone with general properties similar to those of HALOPERIDOL. It is used in conjunction with an opioid analgesic such as FENTANYL to maintain the patient in a calm state of neuroleptanalgesia with indifference to surroundings but still able to cooperate with the surgeon. It is also used as a premedicant, as an antiemetic, and for the control of agitation in acute psychoses. (From Martindale, The Extra Pharmacopoeia, 29th ed, p593)
Accumulations of blood in the PERITONEAL CAVITY due to internal HEMORRHAGE.
Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both.
The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.
The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading.
A synthetic progestational hormone with actions similar to those of PROGESTERONE and about twice as potent as its racemic or (+-)-isomer (NORGESTREL). It is used for contraception, control of menstrual disorders, and treatment of endometriosis.
Blocking the process leading to OVULATION. Various factors are known to inhibit ovulation, such as neuroendocrine, psychological, and pharmacological agents.
Diminished or absent ability of a female to achieve conception.
Diseases of animals within the order PRIMATES. This term includes diseases of Haplorhini and Strepsirhini.
The hormone-responsive glandular layer of ENDOMETRIUM that sloughs off at each menstrual flow (decidua menstrualis) or at the termination of pregnancy. During pregnancy, the thickest part of the decidua forms the maternal portion of the PLACENTA, thus named decidua placentalis. The thin portion of the decidua covering the rest of the embryo is the decidua capsularis.
Pathological processes involving the PERITONEUM.
Contraceptive devices placed high in the uterine fundus.
The discharge of an OVUM from a rupturing follicle in the OVARY.
A major gonadotropin secreted by the human adenohypophysis (PITUITARY GLAND, ANTERIOR). Follicle-stimulating hormone stimulates GAMETOGENESIS and the supporting cells such as the ovarian GRANULOSA CELLS, the testicular SERTOLI CELLS, and the LEYDIG CELLS. FSH consists of two noncovalently linked subunits, alpha and beta. The alpha subunit is common in the three human pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity.
The genital canal in the female, extending from the UTERUS to the VULVA. (Stedman, 25th ed)
The reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE.
Suspension or cessation of OVULATION in animals or humans with follicle-containing ovaries (OVARIAN FOLLICLE). Depending on the etiology, OVULATION may be induced with appropriate therapy.
Connective tissue cells of an organ found in the loose connective tissue. These are most often associated with the uterine mucosa and the ovary as well as the hematopoietic system and elsewhere.
A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Follicle-stimulating hormone stimulates GAMETOGENESIS and the supporting cells such as the ovarian GRANULOSA CELLS, the testicular SERTOLI CELLS, and LEYDIG CELLS. FSH consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity.
A family of zinc-dependent metalloendopeptidases that is involved in the degradation of EXTRACELLULAR MATRIX components.
A synthetic progestin that is derived from 17-hydroxyprogesterone. It is a long-acting contraceptive that is effective both orally or by intramuscular injection and has also been used to treat breast and endometrial neoplasms.
The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
Steroid hormones produced by the GONADS. They stimulate reproductive organs, germ cell maturation, and the secondary sex characteristics in the males and the females. The major sex steroid hormones include ESTRADIOL; PROGESTERONE; and TESTOSTERONE.
A genus of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, consisting of five named species: PAPIO URSINUS (chacma baboon), PAPIO CYNOCEPHALUS (yellow baboon), PAPIO PAPIO (western baboon), PAPIO ANUBIS (or olive baboon), and PAPIO HAMADRYAS (hamadryas baboon). Members of the Papio genus inhabit open woodland, savannahs, grassland, and rocky hill country. Some authors consider MANDRILLUS a subgenus of Papio.
A progestational and glucocorticoid hormone antagonist. Its inhibition of progesterone induces bleeding during the luteal phase and in early pregnancy by releasing endogenous prostaglandins from the endometrium or decidua. As a glucocorticoid receptor antagonist, the drug has been used to treat hypercortisolism in patients with nonpituitary CUSHING SYNDROME.
In females, the period that is shortly after giving birth (PARTURITION).
Endometrial implantation of EMBRYO, MAMMALIAN at the BLASTOCYST stage.
A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity.
Unsaturated derivatives of the ESTRANES with methyl groups at carbon-13, with no carbon at carbon-10, and with no more than one carbon at carbon-17. They must contain one or more double bonds.
Pathological processes involving the female reproductive tract (GENITALIA, FEMALE).
The period before MENOPAUSE. In premenopausal women, the climacteric transition from full sexual maturity to cessation of ovarian cycle takes place between the age of late thirty and early fifty.
Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds.
An extracellular endopeptidase of vertebrate tissues similar to MATRIX METALLOPROTEINASE 1. It digests PROTEOGLYCAN; FIBRONECTIN; COLLAGEN types III, IV, V, and IX, and activates procollagenase. (Enzyme Nomenclature, 1992)
Enzymes that catalyze the degradation of collagen by acting on the peptide bonds.
Elements of limited time intervals, contributing to particular results or situations.

Nitric oxide in the endometrium. (1/815)

Nitric oxide (NO) is an important mediator of paracrine interactions, especially within the vascular system. It is a powerful inhibitor of platelet aggregation and a potent vasodilator. NO is also a neurotransmitter and it plays a role in cell-mediated cytotoxicity. NO-generating enzymes (nitric oxide synthases, NOS) have been described in the endometrium of a number of species, suggesting that NO might be involved in endometrial function. In human endometrium, endothelial NOS and inducible NOS have been localized to glandular epithelium in the non-pregnant uterus. Weak inducible NOS immunoreactivity has been observed in decidualized stromal cells. NO might participate in the initiation and control of menstrual bleeding. Furthermore, it may play a part in the inhibition of platelet aggregation within the endometrium, where menstrual haemostasis is thought to occur primarily by vasoconstriction rather than clot organization. Endometrially derived NO could also suppress myometrial contractility. Recent attention has focused on the part that NO might play in maintaining myometrial quiescence during pregnancy. NO also appears to relax the non-pregnant myometrium, an action which could be exploited for the medical treatment of primary dysmenorrhoea.  (+info)

Mechanism of action and clinical effects of antiprogestins on the non-pregnant uterus. (2/815)

Considerable progress has been made in elucidating the mechanism of action of antiprogestins. The biological response to a progesterone antagonist depends on many factors. The usual effect is that of an antagonist, but progesterone agnostic or even antioestrogenic or oestrogenic effects have also been observed. The present review focuses on the clinical applications of antiprogestins in the non-pregnant uterus. Whereas high doses of antiprogestins block ovulation, low doses impair endometrial development without affecting ovulation, hormonal levels or bleeding patterns Indeed, the endometrium is the tissue which is the most sensitive to antiprogestins. The effect of antiprogestins is to produce a delay in endometrial maturation and to postpone the appearance of the implantation window. This concept of 'endometrial contraception' requires further testing in humans, although the principle has been proven in monkeys. In contrast to the low doses of mifepristone which delay endometrial maturation, a minimum dose of 50 mg is required to produce endometrial bleeding. Late luteal phase antiprogestin administration does not disturb ovulation, hormonal levels or bleeding patterns. This has clinical application, and mifepristone has been used together with prostaglandins in women with delayed menses to successfully prevent implantation. Mifepristone has also been shown to be an effective post-coital agent. However, when used on a regular basis once monthly at the end of the cycle as a potential contraceptive, the results are disappointing. Because of their antiproliferative and anti-oestrogenic effects on the endometrium, antiprogestins are also used in the treatment of oestrogen-dependent conditions such as endometriosis and fibromyomas. In humans, chronic administration of high doses of antiprogestins has on rare occasions been associated with endometrial hyperplasia, presumably a consequence of unopposed oestrogen activity. This does not occur with low doses (1 mg daily for 5 months).  (+info)

Individual growth patterns in the first trimester: evidence for difference in embryonic and fetal growth rates. (3/815)

OBJECTIVE: To evaluate individual fetal growth during the first trimester in pregnancies resulting from spontaneous and in vitro fertilization (IVF). METHODS: The growth of 11 fetuses conceived by spontaneous fertilization (known dates of ovulation) in nine patients and 15 fetuses conceived by IVF in 12 patients were evaluated at weekly intervals from 6 weeks, menstrual age, to 14 weeks. Fetal length was determined at each examination. Measures of fetal length included the crown-rump length (CRL), maximum straight line length (MSLL) and maximum axial length (MAL). Comparisons of CRL and MSLL to MAL were carried out. The MSLL was used as the measure of length except when the MAL was available. Linear and quadratic functions were fitted to the complete data sets of individual fetuses in the two groups. Individual data sets from ten fetuses in each group were then divided into early and late growth phases, and linear functions were fitted to each data subset. Start points and pivotal points for each fetus were estimated from the coefficients of these two functions. Growth in these two groups of fetuses was compared, on the basis of slope values. RESULTS: Evaluation of length measures indicated that, before 8 weeks, only MSLL could be measured. After 8 weeks, all three measures could be obtained, with the MAL being the largest. Both the linear and quadratic models performed well with individual data sets (mean R2(+/- SD): linear 98.1 (1.0)%; quadratic 99.4 (0.4)%), with no differences found between spontaneous and IVF groups (maximum possible differences in mean slopes (95% probability): 5-8%). Similar findings were obtained for the early and late growth phase data subsets. Slope values in the early and late growth phases showed low variability (CV: early 13.5%; late 11.6%), but were significantly different (early 0.72 (+/- 0.10 SD) cm/week; late 1.21 (+/- 0.14 SD) cm/week). The mean start point was 5.9 (+/- 0.3 SD) weeks' menstrual age, while the mean pivotal point was 9.2 (+/- 0.7 SD) weeks, menstrual age. CONCLUSIONS: First-trimester growth studies in individual fetuses indicate that there is a change in length growth rate between 9 and 10 weeks, menstrual age. This is consistent with a shift in development from organogenesis to growth. These results can be used for more accurate assessment of first-trimester growth and may aid in the detection of fetal problems that manifest themselves as growth abnormalities.  (+info)

Clinical interpretation of ultrasound biometry for dating and for assessment of fetal growth using a wheel and chart: is it sufficiently accurate? (4/815)

OBJECTIVES: To investigate how accurately practicing obstetricians (experts) can apply dating rules and compare the interpretation of gestation-sensitive ultrasound data with those of a computer system. SUBJECTS: Seventeen practicing obstetricians. Members of the Royal College of Obstetricians and Gynaecologists, from 14 different units throughout the UK. DESIGN: Six cases with menstrual and ultrasound data together with identical ultrasound charts and obstetric wheels. MAIN OUTCOME MEASURES: Concordance between the calculated estimated date of delivery (EDD) and growth assessment provided by the experts and the computer system. RESULTS: The calculation of the EDD by the experts was imprecise (59% within 3 days overall). Concordance with the computer calculation was poorest when the ultrasound measurements lay close to the upper or lower centile lines (average 7% within 3 days of the computer). Interpretation of growth showed good concordance with the computer when gestation was not critical to the interpretation (94%), but very poor when gestation was critical (7%). CONCLUSIONS: Calculation of EDD by means of an obstetric wheel and charts is not precise. Compared with the computer system, these errors have a significant effect on the subsequent interpretation of growth scans when the data are borderline. A computer system provides the more accurate method for interpreting gestation-sensitive ultrasound biometry.  (+info)

Can transvaginal fetal biometry be considered a useful tool for early detection of skeletal dysplasias in high-risk patients? (5/815)

OBJECTIVE: To evaluate the possibility of an early diagnosis of skeletal dysplasias in high-risk patients. METHODS: A total of 149 consecutive, uncomplicated singleton pregnancies at 9-13 weeks' amenorrhea, with certain menstrual history and regular cycles, were investigated with transvaginal ultrasound to establish the relationship between femur length and menstrual age, biparietal diameter and crown-rump length, using a polynomial regression model. A further eight patients with previous skeletal dysplasias in a total of 13 pregnancies were evaluated with serial examinations every 2 weeks from 10-11 weeks. RESULTS: A significant correlation between femur length and crown-rump length and biparietal diameter was found, whereas none was observed between femur length and menstrual age. Of the five cases with skeletal dysplasias, only two (one with recurrent osteogenesis imperfecta and one with recurrent achondrogenesis) were diagnosed in the first trimester. CONCLUSIONS: An early evaluation of fetal morphology in conjunction with the use of biometric charts of femur length against crown-rump length and femur length against biparietal diameter may be crucial for early diagnosis of severe skeletal dysplasias. By contrast, in less severe cases, biometric evaluation appears to be of no value for diagnosis.  (+info)

Caffeine consumption and menstrual function. (6/815)

The relation between caffeine intake and menstrual function was examined in 403 healthy premenopausal women who belonged to Kaiser Permanente Medical Care Program in 1990-1991. A telephone interview collected information about caffeinated beverage intake as well as other lifestyle, demographic, occupational, and environmental factors. Subjects collected daily urine samples and completed a daily diary for an average of five menstrual cycles. Metabolites of estrogen and progesterone were measured in the urine, each cycle was characterized as anovulatory or ovulatory, and a probable day of ovulation was selected when appropriate. Logistic regression and repeated measures analyses were performed on menstrual parameters. Women whose caffeine consumption was heavy (>300 mg of caffeine per day) had less than a third of the risk for long menses (> or =8 days) compared with women who did not consume caffeine (adjusted odds ratio = 0.30, 95% confidence interval 0.14-0.66). Those whose caffeine consumption was heavy also had a doubled risk for short cycle length (< or =24 days) (adjusted odds ratio = 2.00, 95% confidence interval 0.98-4.06); this association was also evident in those whose caffeine consumption was heavy who did not smoke (adjusted odds ratio = 2.11, 95% confidence interval 1.03-4.33). Caffeine intake was not strongly related to an increased risk for anovulation, short luteal phase (< or =10 days), long follicular phase (> or =24 days), long cycle (> or =36 days), or measures of within-woman cycle variability.  (+info)

Adhesion of shed menstrual tissue in an in-vitro model using amnion and peritoneum: a light and electron microscopic study. (7/815)

We have investigated the adhesion of endometrial tissue isolated from antegradely shed menstrual effluent to amnion and peritoneum. This endometrial tissue was cultured overnight on either side of intact and stripped amnion and on the mesothelial side of peritoneum. Light and electron microscopy were applied to evaluate adhesion. With light microscopy adhesion of endometrial fragments to stripped membranes was observed in nine out of 12 specimens and in 12 out of 13 specimens when layered on the extracellular matrix side of amnion. Adhesion when layered on the epithelial side was seen in only four out of 13 specimens. However, when using scanning electron microscopy adhesion of menstrual endometrial tissue could be visualized in all samples. Numerous adhering fragments were seen when layered on the extracellular matrix side of untreated amnion. On several occasions not only adhesion but also spreading of cells was observed. When layered on the epithelial side of untreated amnion or peritoneum, adhesion was exclusively seen at locations where the epithelium was damaged or absent. These findings were confirmed by transmission electron microscopy. These observations indicate that endometrial tissue isolated from antegradely shed menstrual effluent preferentially adheres to subepithelial structures of amnion and peritoneum. The lack of adhesion to epithelial cells suggests that an intact mesothelial lining prevents adhesion of menstrual endometrial tissue.  (+info)

Apoptosis of human endometrium mediated by perforin and granzyme B of NK cells and cytotoxic T lymphocytes. (8/815)

Endometrial stromal granulocytes (EGs) were found to be a major component of human endometrial stroma in the late secretory phase. However, the role of EGs in the mechanism of human endometrial menstruation has not been clarified. Immunohistochemistry of CD56, perforin, granzyme B, and vimentin, in situ detection of apoptosis by TUNEL (TdT-mediated dUTP-biotin nick and labeling) and electron microscopy were performed in endometrial tissue samples with normal menstrual cycles. We analyzed the number of immunostained cells in the functional layer of stroma and the number of apoptotic cells detected by TUNEL in the endometrial glandular cells. Double-staining revealed that CD56-positive endometrial stromal cells were simultaneously positive for both perforin and granzyme B, and negative for vimentin, which recognized stromal tissue. Vimentin was positive for the predecidual cells and negative for EGs. CD56-positive EGs involving perforin and granzyme B were progressively recruited during the secretory phases before menstruation. Apoptosis in endometrial glandular cells increased from the late secretory phase, which maximized at the menstrual period. This finding suggests that the cytotoxic granules released from EGs, which are derived from cytotoxic T lymphocytes and natural killer cells, are initiators of the apoptotic pathway that induces endometrial menstruation.  (+info)

Menstruation is the regular, cyclical shedding of the uterine lining (endometrium) in women and female individuals of reproductive age, accompanied by the discharge of blood and other materials from the vagina. It typically occurs every 21 to 35 days and lasts for approximately 2-7 days. This process is a part of the menstrual cycle, which is under the control of hormonal fluctuations involving follicle-stimulating hormone (FSH), luteinizing hormone (LH), estrogen, and progesterone.

The menstrual cycle can be divided into three main phases:

1. Menstruation phase: The beginning of the cycle is marked by the start of menstrual bleeding, which signals the breakdown and shedding of the endometrium due to the absence of pregnancy and low levels of estrogen and progesterone. This phase typically lasts for 2-7 days.

2. Proliferative phase: After menstruation, under the influence of rising estrogen levels, the endometrium starts to thicken and regenerate. The uterine lining becomes rich in blood vessels and glands, preparing for a potential pregnancy. This phase lasts from day 5 until around day 14 of an average 28-day cycle.

3. Secretory phase: Following ovulation (release of an egg from the ovaries), which usually occurs around day 14, increased levels of progesterone cause further thickening and maturation of the endometrium. The glands in the lining produce nutrients to support a fertilized egg. If pregnancy does not occur, both estrogen and progesterone levels will drop, leading to menstruation and the start of a new cycle.

Understanding menstruation is essential for monitoring reproductive health, identifying potential issues such as irregular periods or menstrual disorders, and planning family planning strategies.

Menstruation disturbances, also known as menstrual disorders, refer to any irregularities or abnormalities in a woman's menstrual cycle. These disturbances can manifest in various ways, including:

1. Amenorrhea: The absence of menstrual periods for three consecutive cycles or more in women of reproductive age.
2. Oligomenorrhea: Infrequent or light menstrual periods that occur at intervals greater than 35 days.
3. Dysmenorrhea: Painful menstruation, often accompanied by cramping, pelvic pain, and other symptoms that can interfere with daily activities.
4. Menorrhagia: Heavy or prolonged menstrual periods that last longer than seven days or result in excessive blood loss, leading to anemia or other health complications.
5. Polymenorrhea: Abnormally frequent menstrual periods that occur at intervals of 21 days or less.
6. Metrorrhagia: Irregular and unpredictable vaginal bleeding between expected menstrual periods, which can be caused by various factors such as hormonal imbalances, infections, or structural abnormalities.

Menstruation disturbances can have significant impacts on a woman's quality of life, fertility, and overall health. They may result from various underlying conditions, including hormonal imbalances, polycystic ovary syndrome (PCOS), thyroid disorders, uterine fibroids, endometriosis, or sexually transmitted infections. Proper diagnosis and treatment of the underlying cause are essential for managing menstruation disturbances effectively.

The menstrual cycle is a series of natural changes that occur in the female reproductive system over an approximate 28-day interval, marking the body's preparation for potential pregnancy. It involves the interplay of hormones that regulate the growth and disintegration of the uterine lining (endometrium) and the release of an egg (ovulation) from the ovaries.

The menstrual cycle can be divided into three main phases:

1. Menstrual phase: The cycle begins with the onset of menstruation, where the thickened uterine lining is shed through the vagina, lasting typically for 3-7 days. This shedding occurs due to a decrease in estrogen and progesterone levels, which are hormones essential for maintaining the endometrium during the previous cycle.

2. Follicular phase: After menstruation, the follicular phase commences with the pituitary gland releasing follicle-stimulating hormone (FSH). FSH stimulates the growth of several ovarian follicles, each containing an immature egg. One dominant follicle usually becomes selected to mature and release an egg during ovulation. Estrogen levels rise as the dominant follicle grows, causing the endometrium to thicken in preparation for a potential pregnancy.

3. Luteal phase: Following ovulation, the ruptured follicle transforms into the corpus luteum, which produces progesterone and estrogen to further support the endometrial thickening. If fertilization does not occur within approximately 24 hours after ovulation, the corpus luteum will degenerate, leading to a decline in hormone levels. This drop triggers the onset of menstruation, initiating a new menstrual cycle.

Understanding the menstrual cycle is crucial for monitoring reproductive health and planning or preventing pregnancies. Variations in cycle length and symptoms are common among women, but persistent irregularities may indicate underlying medical conditions requiring further evaluation by a healthcare professional.

Menstrual hygiene products are items used by menstruating individuals to absorb or collect blood and maintain cleanliness and comfort during menstruation. These products typically include sanitary napkins, tampons, menstrual cups, and reusable cloth pads. They are designed to be safe, comfortable, and effective in managing menstrual flow and preventing leakage, while also being convenient and discreet to use. It is essential to maintain proper menstrual hygiene to prevent discomfort, skin irritation, and infection during menstruation.

Dysmenorrhea is a medical term that refers to painful menstrual cramps and discomfort during menstruation. It's one of the most common gynecological complaints among women of reproductive age. There are two types of dysmenorrhea: primary and secondary.

1. Primary Dysmenorrhea: This type is more common and occurs in women who have had normal, pelvic anatomy. The pain is caused by strong contractions of the uterus due to the production of prostaglandins (hormone-like substances that are involved in inflammation and pain). Primary dysmenorrhea usually starts soon after menarche (the beginning of menstruation) and tends to improve with age, particularly after childbirth.
2. Secondary Dysmenorrhea: This type is less common and occurs due to an underlying medical condition affecting the reproductive organs, such as endometriosis, uterine fibroids, pelvic inflammatory disease (PID), or adenomyosis. The pain associated with secondary dysmenorrhea tends to worsen over time and may be accompanied by other symptoms like irregular menstrual bleeding, pain during intercourse, or chronic pelvic pain.

Treatment for dysmenorrhea depends on the type and underlying cause. For primary dysmenorrhea, nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or naproxen can help alleviate pain by reducing prostaglandin production. Hormonal birth control methods like oral contraceptives and intrauterine devices (IUDs) may also be prescribed to reduce menstrual pain. For secondary dysmenorrhea, treatment typically involves addressing the underlying medical condition causing the pain.

The endometrium is the innermost layer of the uterus, which lines the uterine cavity and has a critical role in the menstrual cycle and pregnancy. It is composed of glands and blood vessels that undergo cyclic changes under the influence of hormones, primarily estrogen and progesterone. During the menstrual cycle, the endometrium thickens in preparation for a potential pregnancy. If fertilization does not occur, it will break down and be shed, resulting in menstruation. In contrast, if implantation takes place, the endometrium provides essential nutrients to support the developing embryo and placenta throughout pregnancy.

Amenorrhea is a medical condition characterized by the absence or cessation of menstrual periods in women of reproductive age. It can be categorized as primary amenorrhea, when a woman who has not yet had her first period at the expected age (usually around 16 years old), or secondary amenorrhea, when a woman who has previously had regular periods stops getting them for six months or more.

There are various causes of amenorrhea, including hormonal imbalances, pregnancy, breastfeeding, menopause, extreme weight loss or gain, eating disorders, intense exercise, stress, chronic illness, tumors, and certain medications or medical treatments. In some cases, amenorrhea may indicate an underlying medical condition that requires further evaluation and treatment.

Amenorrhea can have significant impacts on a woman's health and quality of life, including infertility, bone loss, and emotional distress. Therefore, it is essential to consult with a healthcare provider if you experience amenorrhea or missed periods to determine the underlying cause and develop an appropriate treatment plan.

Menstruation-inducing agents, also known as menstrual induction agents or abortifacients, are medications or substances that stimulate or induce menstruation and can potentially lead to the termination of an early pregnancy. These agents work by causing the uterus to contract and expel its lining (endometrium), which is shed during menstruation.

Common menstruation-inducing agents include:

1. Hormonal medications: Combination oral contraceptives, containing both estrogen and progestin, can be used to induce menstruation by causing the uterus to shed its lining after a planned break from taking the medication. This is often used in birth control methods like the "birth control pill pack."
2. Prostaglandins: These are naturally occurring hormone-like substances that can cause the uterus to contract. Synthetic prostaglandin analogs, such as misoprostol (Cytotec), can be used to induce menstruation or early pregnancy termination.
3. Mifepristone: This is a synthetic steroid hormone that blocks progesterone receptors in the body. When used in combination with prostaglandins, it can cause the uterus to contract and expel its lining, leading to an abortion or inducing menstruation.

It's important to note that using menstruation-inducing agents without medical supervision or for purposes other than their intended use may pose health risks and should be avoided. Always consult a healthcare professional before using any medication for this purpose.

Menorrhagia is a medical term used to describe abnormally heavy or prolonged menstrual periods. It's often characterized by the loss of an excessive amount of menstrual blood (usually more than 80 ml) and can last longer than normal, typically over seven days. This condition can have significant impacts on a woman's quality of life, causing fatigue, distress, and restrictions in daily activities due to the need for frequent pad or tampon changes.

The causes of menorrhagia are varied and can include hormonal imbalances, uterine fibroids or polyps, endometrial hyperplasia, pelvic inflammatory disease, pregnancy complications, certain medications, and underlying medical conditions such as coagulopathies or thyroid disorders. In some cases, the cause may remain undetermined even after a thorough evaluation.

Treatment options for menorrhagia depend on the underlying cause and range from medication management with hormonal therapies, nonsteroidal anti-inflammatory drugs (NSAIDs), or tranexamic acid to procedural interventions like endometrial ablation, hysteroscopic resection of polyps or fibroids, or ultimately hysterectomy in severe cases. It is essential for individuals experiencing menorrhagia to consult with their healthcare provider to determine the best course of action based on their specific situation and medical history.

Endometriosis is a medical condition in which tissue similar to the lining of the uterus (endometrium) grows outside the uterine cavity, most commonly on the ovaries, fallopian tubes, and the pelvic peritoneum. This misplaced endometrial tissue continues to act as it would inside the uterus, thickening, breaking down, and bleeding with each menstrual cycle. However, because it is outside the uterus, this blood and tissue have no way to exit the body and can lead to inflammation, scarring, and the formation of adhesions (tissue bands that bind organs together).

The symptoms of endometriosis may include pelvic pain, heavy menstrual periods, painful intercourse, and infertility. The exact cause of endometriosis is not known, but several theories have been proposed, including retrograde menstruation (the backflow of menstrual blood through the fallopian tubes into the pelvic cavity), genetic factors, and immune system dysfunction.

Endometriosis can be diagnosed through a combination of methods, such as medical history, physical examination, imaging tests like ultrasound or MRI, and laparoscopic surgery with tissue biopsy. Treatment options for endometriosis include pain management, hormonal therapies, and surgical intervention to remove the misplaced endometrial tissue. In severe cases, a hysterectomy (removal of the uterus) may be recommended, but this is typically considered a last resort due to its impact on fertility and quality of life.

Premenstrual Syndrome (PMS) is a complex of symptoms that occur in the latter part of the luteal phase (the second half) of the menstrual cycle, typically starting 5-11 days before the onset of menses, and remitting shortly after the onset of menstruation. The symptoms can be physical, psychological, or behavioral and vary from mild to severe. They include but are not limited to: bloating, breast tenderness, cramps, headaches, mood swings, irritability, depression, anxiety, fatigue, changes in appetite, and difficulty concentrating.

The exact cause of PMS is not known, but it appears to be related to hormonal changes during the menstrual cycle, particularly fluctuations in estrogen and progesterone levels. Some women may be more susceptible to these hormonal shifts due to genetic factors, neurotransmitter imbalances, or other health conditions.

Treatment for PMS often involves a combination of lifestyle changes (such as regular exercise, stress management, and dietary modifications), over-the-counter pain relievers, and, in some cases, hormonal medications or antidepressants. It's important to consult with a healthcare provider for an accurate diagnosis and treatment plan.

Menarche is the first occurrence of menstruation in a female adolescent, indicating the onset of reproductive capability. It usually happens between the ages of 10 and 16, with an average age of around 12-13 years old, but it can vary widely from one individual to another due to various factors such as genetics, nutrition, and overall health.

Achieving menarche is a significant milestone in a girl's life, signaling the transition from childhood to adolescence. It is also an essential indicator of sexual maturation, often used in conjunction with other physical changes to assess pubertal development. However, it does not necessarily mean that a girl is psychologically or emotionally prepared for menstruation and sexual activity; therefore, appropriate education and support are crucial during this period.

Progesterone is a steroid hormone that is primarily produced in the ovaries during the menstrual cycle and in pregnancy. It plays an essential role in preparing the uterus for implantation of a fertilized egg and maintaining the early stages of pregnancy. Progesterone works to thicken the lining of the uterus, creating a nurturing environment for the developing embryo.

During the menstrual cycle, progesterone is produced by the corpus luteum, a temporary structure formed in the ovary after an egg has been released from a follicle during ovulation. If pregnancy does not occur, the levels of progesterone will decrease, leading to the shedding of the uterine lining and menstruation.

In addition to its reproductive functions, progesterone also has various other effects on the body, such as helping to regulate the immune system, supporting bone health, and potentially influencing mood and cognition. Progesterone can be administered medically in the form of oral pills, intramuscular injections, or vaginal suppositories for various purposes, including hormone replacement therapy, contraception, and managing certain gynecological conditions.

Lynestrenol is a synthetic form of progestogen, which is a female sex hormone. It is used in various medications for different purposes, such as treating abnormal menstrual bleeding, endometriosis, and preventing premature labor. Lynestrenol works by mimicking the effects of natural progesterone in the body, helping to regulate the menstrual cycle and reduce inflammation associated with endometriosis. It is important to note that lynestrenol should only be used under the supervision of a healthcare professional, as it can have side effects and interact with other medications.

The luteal phase is the second half of the menstrual cycle, starting from ovulation (release of an egg from the ovaries) and lasting until the start of the next menstruation. This phase typically lasts around 12-14 days in a regular 28-day menstrual cycle. During this phase, the remains of the dominant follicle that released the egg transform into the corpus luteum, which produces progesterone and some estrogen to support the implantation of a fertilized egg and maintain the early stages of pregnancy. If pregnancy does not occur, the corpus luteum degenerates, leading to a drop in hormone levels and the start of a new menstrual cycle.

The uterus, also known as the womb, is a hollow, muscular organ located in the female pelvic cavity, between the bladder and the rectum. It has a thick, middle layer called the myometrium, which is composed of smooth muscle tissue, and an inner lining called the endometrium, which provides a nurturing environment for the fertilized egg to develop into a fetus during pregnancy.

The uterus is where the baby grows and develops until it is ready for birth through the cervix, which is the lower, narrow part of the uterus that opens into the vagina. The uterus plays a critical role in the menstrual cycle as well, by shedding its lining each month if pregnancy does not occur.

Oligomenorrhea is a medical term used to describe infrequent menstrual periods, where the cycle length is more than 35 days but less than 68 days. It's considered a menstrual disorder and can affect people of reproductive age. The causes of oligomenorrhea are varied, including hormonal imbalances, polycystic ovary syndrome (PCOS), thyroid disorders, excessive exercise, significant weight loss or gain, and stress. In some cases, it may not cause any other symptoms, but in others, it can be associated with infertility, hirsutism (excessive hair growth), acne, or obesity. Treatment depends on the underlying cause and may include lifestyle modifications, hormonal medications, or surgery in rare cases.

Dydrogesterone is a synthetic form of the natural hormone progesterone, which is used in various forms of medical therapy. It is primarily used as a hormonal supplement during infertility treatments and to prevent pregnancy loss in women with a history of miscarriage due to progesterone deficiency.

Dydrogesterone works by mimicking the effects of natural progesterone, which helps to prepare the lining of the uterus for implantation of a fertilized egg and supports the early stages of pregnancy. It is also used in the treatment of endometriosis, a condition where tissue similar to the lining of the uterus grows outside of it, causing pain and other symptoms.

Dydrogesterone is available in various forms, including tablets and capsules, and is typically taken orally. The dosage and duration of treatment may vary depending on the specific medical condition being treated and the individual patient's needs. As with any medication, dydrogesterone should only be used under the guidance and supervision of a qualified healthcare provider.

Uterine hemorrhage, also known as uterine bleeding or gynecological bleeding, is an abnormal loss of blood from the uterus. It can occur in various clinical settings such as menstruation (known as menorrhagia), postpartum period (postpartum hemorrhage), or in non-pregnant women (dysfunctional uterine bleeding). The bleeding may be light to heavy, intermittent or continuous, and can be accompanied by symptoms such as pain, dizziness, or fainting. Uterine hemorrhage is a common gynecological problem that can have various underlying causes, including hormonal imbalances, structural abnormalities, coagulopathies, and malignancies. It is important to seek medical attention if experiencing heavy or prolonged uterine bleeding to determine the cause and receive appropriate treatment.

Ethamsylate is a medication that belongs to a class of drugs known as anti-fibrinolytics. It works by helping to prevent the breakdown of blood clots and promoting the healing of damaged blood vessels. Ethamsylate is often used in the treatment of conditions associated with bleeding, such as menorrhagia (heavy menstrual periods) and various types of hemorrhage (severe bleeding).

The chemical name for Ethamsylate is diethylammonium 3,4-dimethoxybenzenesulfonate. It is available in oral tablet form and is typically prescribed to be taken two to three times a day, depending on the severity of the condition being treated. As with any medication, it's important to follow your healthcare provider's instructions carefully when taking Ethamsylate.

While Ethamsylate can be effective in treating certain types of bleeding, it is not without potential side effects. Common side effects may include gastrointestinal symptoms such as nausea, vomiting, and diarrhea. In rare cases, more serious side effects such as allergic reactions, kidney damage, or changes in blood pressure may occur. If you experience any unusual symptoms while taking Ethamsylate, it's important to contact your healthcare provider right away.

The follicular phase is a term used in reproductive endocrinology, which refers to the first part of the menstrual cycle. This phase begins on the first day of menstruation and lasts until ovulation. During this phase, several follicles in the ovaries begin to mature under the influence of follicle-stimulating hormone (FSH) released by the pituitary gland.

Typically, one follicle becomes dominant and continues to mature, while the others regress. The dominant follicle produces increasing amounts of estrogen, which causes the lining of the uterus to thicken in preparation for a possible pregnancy. The follicular phase can vary in length, but on average it lasts about 14 days.

It's important to note that the length and characteristics of the follicular phase can provide valuable information in diagnosing various reproductive disorders, such as polycystic ovary syndrome (PCOS) or thyroid dysfunction.

Droperidol is a butyrophenone neuroleptic medication that is primarily used for its antiemetic (anti-nausea and vomiting) properties. It works by blocking dopamine receptors in the brain, which can help to reduce feelings of nausea and vomiting caused by various factors such as chemotherapy, surgery, or motion sickness.

Droperidol is also known for its sedative and anxiolytic (anxiety-reducing) effects, and has been used in the past as a premedication before surgery to help reduce anxiety and produce sedation. However, due to concerns about rare but serious side effects such as QT prolongation (a heart rhythm disorder), droperidol is now less commonly used for this purpose.

Droperidol is available in injectable form and is typically administered by healthcare professionals in a hospital or clinical setting. It should be used with caution and only under the close supervision of a healthcare provider, as it can cause a range of side effects including dizziness, drowsiness, dry mouth, and restlessness. More serious side effects such as seizures, irregular heartbeat, and neuroleptic malignant syndrome (a rare but potentially life-threatening condition characterized by muscle rigidity, fever, and autonomic instability) have also been reported with droperidol use.

Hemoperitoneum is a medical condition characterized by the presence of blood in the peritoneal cavity, which is the space between the lining of the abdominal wall and the organs within it. This can occur due to various reasons such as trauma, rupture of an abdominal aortic aneurysm, ectopic pregnancy, or other conditions that cause bleeding into the abdomen.

The accumulation of blood in the peritoneal cavity can lead to symptoms such as abdominal pain, tenderness, distension, and hypovolemic shock due to blood loss. Hemoperitoneum is a serious medical condition that requires prompt diagnosis and treatment to prevent further complications.

Oral contraceptives, also known as "birth control pills," are medications taken by mouth to prevent pregnancy. They contain synthetic hormones that mimic the effects of natural hormones estrogen and progesterone in a woman's body, thereby preventing ovulation, fertilization, or implantation of a fertilized egg in the uterus.

There are two main types of oral contraceptives: combined pills, which contain both estrogen and progestin, and mini-pills, which contain only progestin. Combined pills work by preventing ovulation, thickening cervical mucus to make it harder for sperm to reach the egg, and thinning the lining of the uterus to make it less likely for a fertilized egg to implant. Mini-pills work mainly by thickening cervical mucus and changing the lining of the uterus.

Oral contraceptives are highly effective when used correctly, but they do not protect against sexually transmitted infections (STIs). It is important to use them consistently and as directed by a healthcare provider. Side effects may include nausea, breast tenderness, headaches, mood changes, and irregular menstrual bleeding. In rare cases, oral contraceptives may increase the risk of serious health problems such as blood clots, stroke, or liver tumors. However, for most women, the benefits of using oral contraceptives outweigh the risks.

Estradiol is a type of estrogen, which is a female sex hormone. It is the most potent and dominant form of estrogen in humans. Estradiol plays a crucial role in the development and maintenance of secondary sexual characteristics in women, such as breast development and regulation of the menstrual cycle. It also helps maintain bone density, protect the lining of the uterus, and is involved in cognition and mood regulation.

Estradiol is produced primarily by the ovaries, but it can also be synthesized in smaller amounts by the adrenal glands and fat cells. In men, estradiol is produced from testosterone through a process called aromatization. Abnormal levels of estradiol can contribute to various health issues, such as hormonal imbalances, infertility, osteoporosis, and certain types of cancer.

Pregnancy is a physiological state or condition where a fertilized egg (zygote) successfully implants and grows in the uterus of a woman, leading to the development of an embryo and finally a fetus. This process typically spans approximately 40 weeks, divided into three trimesters, and culminates in childbirth. Throughout this period, numerous hormonal and physical changes occur to support the growing offspring, including uterine enlargement, breast development, and various maternal adaptations to ensure the fetus's optimal growth and well-being.

Contraceptive agents, female, are medications or devices specifically designed to prevent pregnancy in women. They work by interfering with the normal process of ovulation, fertilization, or implantation of a fertilized egg in the uterus. Some common examples of female contraceptive agents include:

1. Hormonal methods: These include combined oral contraceptives (COCs), progestin-only pills, patches, vaginal rings, and hormonal implants. They contain synthetic forms of the female hormones estrogen and/or progesterone, which work by preventing ovulation, thickening cervical mucus to make it harder for sperm to reach the egg, or thinning the lining of the uterus to prevent implantation of a fertilized egg.
2. Intrauterine devices (IUDs): These are small, T-shaped devices made of plastic or copper that are inserted into the uterus by a healthcare provider. They release hormones or copper ions that interfere with sperm movement and prevent fertilization or implantation.
3. Barrier methods: These include condoms, diaphragms, cervical caps, and sponges. They work by physically preventing sperm from reaching the egg.
4. Emergency contraception: This includes medications such as Plan B or Ella, which can be taken up to 5 days after unprotected sex to prevent pregnancy. They work by delaying ovulation or preventing fertilization of the egg.
5. Fertility awareness-based methods (FABMs): These involve tracking a woman's menstrual cycle and avoiding sexual intercourse during her fertile window. Some FABMs also involve using barrier methods during this time.

It is important to note that different contraceptive agents have varying levels of effectiveness, side effects, and risks. Women should consult with their healthcare provider to determine the best method for their individual needs and circumstances.

Levonorgestrel is a synthetic form of the natural hormone progesterone, which is used in various forms of birth control and emergency contraceptives. It works by preventing ovulation (the release of an egg from the ovaries), thickening cervical mucus to make it harder for sperm to reach the egg, and thinning the lining of the uterus to make it less likely for a fertilized egg to implant.

Medically, Levonorgestrel is classified as a progestin and is available in various forms, including oral tablets, intrauterine devices (IUDs), and emergency contraceptive pills. It may also be used to treat endometriosis, irregular menstrual cycles, and heavy menstrual bleeding.

It's important to note that while Levonorgestrel is a highly effective form of birth control when used correctly, it does not protect against sexually transmitted infections (STIs). Therefore, condoms should still be used during sexual activity if there is any risk of STI transmission.

Ovulation inhibition is a term used in reproductive medicine to describe the prevention or delay of ovulation, which is the release of a mature egg from the ovaries during the menstrual cycle. This can be achieved through various means, such as hormonal contraceptives (birth control pills, patches, rings), injectable hormones, or intrauterine devices (IUDs) that release hormones.

Hormonal contraceptives typically contain synthetic versions of the hormones estrogen and progestin, which work together to inhibit the natural hormonal signals that trigger ovulation. By suppressing the surge in luteinizing hormone (LH) and follicle-stimulating hormone (FSH), these methods prevent the development and release of a mature egg from the ovaries.

In addition to preventing ovulation, hormonal contraceptives can also thicken cervical mucus, making it more difficult for sperm to reach the egg, and thin the lining of the uterus, reducing the likelihood of implantation in case fertilization does occur. It is important to note that while ovulation inhibition is a reliable method of birth control, it may not provide protection against sexually transmitted infections (STIs).

Female infertility is a condition characterized by the inability to conceive after 12 months or more of regular, unprotected sexual intercourse or the inability to carry a pregnancy to a live birth. The causes of female infertility can be multifactorial and may include issues with ovulation, damage to the fallopian tubes or uterus, endometriosis, hormonal imbalances, age-related factors, and other medical conditions.

Some common causes of female infertility include:

1. Ovulation disorders: Conditions such as polycystic ovary syndrome (PCOS), thyroid disorders, premature ovarian failure, and hyperprolactinemia can affect ovulation and lead to infertility.
2. Damage to the fallopian tubes: Pelvic inflammatory disease, endometriosis, or previous surgeries can cause scarring and blockages in the fallopian tubes, preventing the egg and sperm from meeting.
3. Uterine abnormalities: Structural issues with the uterus, such as fibroids, polyps, or congenital defects, can interfere with implantation and pregnancy.
4. Age-related factors: As women age, their fertility declines due to a decrease in the number and quality of eggs.
5. Other medical conditions: Certain medical conditions, such as diabetes, celiac disease, and autoimmune disorders, can contribute to infertility.

In some cases, female infertility can be treated with medications, surgery, or assisted reproductive technologies (ART) like in vitro fertilization (IVF). A thorough evaluation by a healthcare professional is necessary to determine the underlying cause and develop an appropriate treatment plan.

Primatology is the study of primates, which includes humans and non-human primates such as monkeys, apes, and lemurs. Primate diseases refer to the range of infectious and non-infectious health conditions that affect these animals. These diseases can be caused by various factors including bacteria, viruses, parasites, fungi, genetics, environmental conditions, and human activities such as habitat destruction, hunting, and keeping primates as pets.

Examples of primate diseases include:

1. Retroviral infections: Primates are susceptible to retroviruses, including simian immunodeficiency virus (SIV) which is the precursor to human immunodeficiency virus (HIV).
2. Herpesviruses: Many primate species are infected with herpesviruses that can cause a range of diseases from mild skin infections to severe neurological disorders.
3. Tuberculosis: Primates can contract tuberculosis, which is caused by the bacterium Mycobacterium tuberculosis and can affect multiple organs.
4. Malaria: Primates are hosts to various species of Plasmodium parasites that cause malaria.
5. Hepatitis: Primates can be infected with hepatitis viruses, including hepatitis B and C.
6. Respiratory infections: Primates can suffer from respiratory infections caused by bacteria, viruses, or fungi.
7. Gastrointestinal diseases: Primates can develop gastrointestinal disorders due to bacterial, viral, or parasitic infections.
8. Neurological disorders: Primates can suffer from neurological conditions such as encephalitis and meningitis caused by various pathogens.
9. Reproductive diseases: Primates can experience reproductive health issues due to infectious agents or environmental factors.
10. Cancer: Primates, like humans, can develop cancer, which can be caused by genetic predisposition, viral infections, or environmental factors.

Understanding primate diseases is crucial for the conservation of endangered species, managing zoonotic diseases that can spread from animals to humans, and advancing medical research, particularly in the fields of infectious diseases and cancer.

The decidua is a specialized type of tissue that lines the uterus during pregnancy. It forms after the implantation of a fertilized egg (embryo) into the uterine lining, and it plays an important role in supporting the growth and development of the embryo and fetus.

The decidua is composed of several layers, including the decidual capsularis, which surrounds the embryo, and the decidual parietalis, which lines the rest of the uterus. The tissue is rich in blood vessels and contains a variety of immune cells that help to protect the developing fetus from infection.

During pregnancy, the decidua produces various hormones and growth factors that support the growth of the placenta, which provides nutrients and oxygen to the fetus. After the birth of the baby, the decidua is shed along with the placenta in a process called childbirth or parturition.

It's worth noting that abnormalities in the decidua can contribute to pregnancy complications such as preeclampsia, preterm labor, and miscarriage.

Peritoneal diseases refer to a group of conditions that affect the peritoneum, which is the thin, transparent membrane that lines the inner wall of the abdomen and covers the organs within it. The peritoneum has several functions, including providing protection and support to the abdominal organs, producing and absorbing fluids, and serving as a site for the immune system's response to infections and other foreign substances.

Peritoneal diseases can be broadly classified into two categories: infectious and non-infectious. Infectious peritoneal diseases are caused by bacterial, viral, fungal, or parasitic infections that spread to the peritoneum from other parts of the body or through contaminated food, water, or medical devices. Non-infectious peritoneal diseases, on the other hand, are not caused by infections but rather by other factors such as autoimmune disorders, cancer, or chemical irritants.

Some examples of peritoneal diseases include:

1. Peritonitis: Inflammation of the peritoneum due to bacterial or fungal infections, often caused by a ruptured appendix, perforated ulcer, or other abdominal injuries or conditions.
2. Tuberculous peritonitis: A form of peritonitis caused by Mycobacterium tuberculosis, the bacterium that causes tuberculosis (TB).
3. Peritoneal dialysis-associated peritonitis: Infection of the peritoneum in patients undergoing peritoneal dialysis, a type of kidney replacement therapy for patients with end-stage renal disease.
4. Malignant peritoneal mesothelioma: A rare and aggressive form of cancer that affects the mesothelial cells lining the peritoneum, often caused by exposure to asbestos.
5. Systemic lupus erythematosus (SLE): An autoimmune disorder that can cause inflammation and scarring of the peritoneum.
6. Peritoneal carcinomatosis: The spread of cancer cells from other parts of the body to the peritoneum, often seen in patients with advanced ovarian or colorectal cancer.
7. Cirrhotic ascites: Fluid accumulation in the peritoneal cavity due to liver cirrhosis and portal hypertension.
8. Meigs' syndrome: A rare condition characterized by the presence of a benign ovarian tumor, ascites, and pleural effusion.

An Intrauterine Device (IUD) is a long-acting, reversible contraceptive device that is inserted into the uterus to prevent pregnancy. It is a small T-shaped piece of flexible plastic with strings attached to it for removal. There are two types of IUDs available: hormonal and copper. Hormonal IUDs release progestin, which thickens cervical mucus and thins the lining of the uterus, preventing sperm from reaching and fertilizing an egg. Copper IUDs, on the other hand, produce an inflammatory reaction in the uterus that is toxic to sperm and eggs, preventing fertilization.

IUDs are more than 99% effective at preventing pregnancy and can remain in place for several years, depending on the type. They are easily removable by a healthcare provider if a woman wants to become pregnant or choose another form of contraception. IUDs do not protect against sexually transmitted infections (STIs), so it is important to use condoms in addition to an IUD for protection against STIs.

In summary, Intrauterine Devices are small, T-shaped plastic devices that are inserted into the uterus to prevent pregnancy. They come in two types: hormonal and copper, both of which work by preventing fertilization. IUDs are highly effective, long-acting, and reversible forms of contraception.

Ovulation is the medical term for the release of a mature egg from an ovary during a woman's menstrual cycle. The released egg travels through the fallopian tube where it may be fertilized by sperm if sexual intercourse has occurred recently. If the egg is not fertilized, it will break down and leave the body along with the uterine lining during menstruation. Ovulation typically occurs around day 14 of a 28-day menstrual cycle, but the timing can vary widely from woman to woman and even from cycle to cycle in the same woman.

During ovulation, there are several physical changes that may occur in a woman's body, such as an increase in basal body temperature, changes in cervical mucus, and mild cramping or discomfort on one side of the lower abdomen (known as mittelschmerz). These symptoms can be used to help predict ovulation and improve the chances of conception.

It's worth noting that some medical conditions, such as polycystic ovary syndrome (PCOS) or premature ovarian failure, may affect ovulation and make it difficult for a woman to become pregnant. In these cases, medical intervention may be necessary to help promote ovulation and increase the chances of conception.

Follicle-Stimulating Hormone (FSH) is a glycoprotein hormone secreted by the anterior pituitary gland. In humans, FSH plays a crucial role in the reproductive system. Specifically, in females, it stimulates the growth of ovarian follicles in the ovary and the production of estrogen. In males, FSH promotes the formation of sperm within the testes' seminiferous tubules. The human FSH is a heterodimer, consisting of two noncovalently associated subunits: α (alpha) and β (beta). The alpha subunit is common to several pituitary hormones, including thyroid-stimulating hormone (TSH), luteinizing hormone (LH), and human chorionic gonadotropin (hCG). In contrast, the beta subunit is unique to FSH and determines its biological specificity. The regulation of FSH secretion is primarily controlled by the hypothalamic-pituitary axis, involving complex feedback mechanisms with gonadal steroid hormones and inhibins.

The vagina is the canal that joins the cervix (the lower part of the uterus) to the outside of the body. It also is known as the birth canal because babies pass through it during childbirth. The vagina is where sexual intercourse occurs and where menstrual blood exits the body. It has a flexible wall that can expand and retract. During sexual arousal, the vaginal walls swell with blood to become more elastic in order to accommodate penetration.

It's important to note that sometimes people use the term "vagina" to refer to the entire female genital area, including the external structures like the labia and clitoris. But technically, these are considered part of the vulva, not the vagina.

An ovary is a part of the female reproductive system in which ova or eggs are produced through the process of oogenesis. They are a pair of solid, almond-shaped structures located one on each side of the uterus within the pelvic cavity. Each ovary measures about 3 to 5 centimeters in length and weighs around 14 grams.

The ovaries have two main functions: endocrine (hormonal) function and reproductive function. They produce and release eggs (ovulation) responsible for potential fertilization and development of an embryo/fetus during pregnancy. Additionally, they are essential in the production of female sex hormones, primarily estrogen and progesterone, which regulate menstrual cycles, sexual development, and reproduction.

During each menstrual cycle, a mature egg is released from one of the ovaries into the fallopian tube, where it may be fertilized by sperm. If not fertilized, the egg, along with the uterine lining, will be shed, leading to menstruation.

Anovulation is a medical condition in which there is a failure to ovulate, or release a mature egg from the ovaries, during a menstrual cycle. This can occur due to various reasons such as hormonal imbalances, polycystic ovary syndrome (PCOS), premature ovarian failure, excessive exercise, stress, low body weight, or certain medications. Anovulation is common in women with irregular menstrual cycles and can cause infertility if left untreated. In some cases, anovulation may be treated with medication to stimulate ovulation.

Stromal cells, also known as stromal/stroma cells, are a type of cell found in various tissues and organs throughout the body. They are often referred to as the "connective tissue" or "supporting framework" of an organ because they play a crucial role in maintaining the structure and function of the tissue. Stromal cells include fibroblasts, adipocytes (fat cells), and various types of progenitor/stem cells. They produce and maintain the extracellular matrix, which is the non-cellular component of tissues that provides structural support and biochemical cues for other cells. Stromal cells also interact with immune cells and participate in the regulation of the immune response. In some contexts, "stromal cells" can also refer to cells found in the microenvironment of tumors, which can influence cancer growth and progression.

Follicle-Stimulating Hormone (FSH) is a glycoprotein hormone secreted and released by the anterior pituitary gland. In females, it promotes the growth and development of ovarian follicles in the ovary, which ultimately leads to the maturation and release of an egg (ovulation). In males, FSH stimulates the testes to produce sperm. It works in conjunction with luteinizing hormone (LH) to regulate reproductive processes. The secretion of FSH is controlled by the hypothalamic-pituitary-gonadal axis and its release is influenced by the levels of gonadotropin-releasing hormone (GnRH), estrogen, inhibin, and androgens.

Matrix metalloproteinases (MMPs) are a group of enzymes responsible for the degradation and remodeling of the extracellular matrix, the structural framework of most tissues in the body. These enzymes play crucial roles in various physiological processes such as tissue repair, wound healing, and embryonic development. They also participate in pathological conditions like tumor invasion, metastasis, and inflammatory diseases by breaking down the components of the extracellular matrix, including collagens, elastins, proteoglycans, and gelatins. MMPs are zinc-dependent endopeptidases that require activation from their proenzyme form to become fully functional. Their activity is tightly regulated at various levels, including gene expression, protein synthesis, and enzyme inhibition by tissue inhibitors of metalloproteinases (TIMPs). Dysregulation of MMPs has been implicated in several diseases, making them potential therapeutic targets for various clinical interventions.

Medroxyprogesterone Acetate (MPA) is a synthetic form of the natural hormone progesterone, which is often used in various medical applications. It is a white to off-white crystalline powder, slightly soluble in water, and freely soluble in alcohol, chloroform, and methanol.

Medically, MPA is used as a prescription medication for several indications, including:

1. Contraception: As an oral contraceptive or injectable solution, it can prevent ovulation, thicken cervical mucus to make it harder for sperm to reach the egg, and alter the lining of the uterus to make it less likely for a fertilized egg to implant.
2. Hormone replacement therapy (HRT): In postmenopausal women, MPA can help manage symptoms associated with decreased estrogen levels, such as hot flashes and vaginal dryness. It may also help prevent bone loss (osteoporosis).
3. Endometrial hyperplasia: MPA can be used to treat endometrial hyperplasia, a condition where the lining of the uterus becomes too thick, which could potentially lead to cancer if left untreated. By opposing the effects of estrogen, MPA helps regulate the growth of the endometrium.
4. Gynecological disorders: MPA can be used to treat various gynecological disorders, such as irregular menstrual cycles, amenorrhea (absence of menstruation), and dysfunctional uterine bleeding.
5. Cancer treatment: In some cases, MPA may be used in conjunction with other medications to treat certain types of breast or endometrial cancer.

As with any medication, Medroxyprogesterone Acetate can have side effects and potential risks. It is essential to consult a healthcare professional for proper evaluation, dosage, and monitoring when considering this medication.

Menopause is a natural biological process that typically occurs in women in their mid-40s to mid-50s. It marks the end of menstrual cycles and fertility, defined as the absence of menstruation for 12 consecutive months. This transition period can last several years and is often accompanied by various physical and emotional symptoms such as hot flashes, night sweats, mood changes, sleep disturbances, and vaginal dryness. The hormonal fluctuations during this time, particularly the decrease in estrogen levels, contribute to these symptoms. It's essential to monitor and manage these symptoms to maintain overall health and well-being during this phase of life.

Gonadal steroid hormones, also known as gonadal sex steroids, are hormones that are produced and released by the gonads (i.e., ovaries in women and testes in men). These hormones play a critical role in the development and maintenance of secondary sexual characteristics, reproductive function, and overall health.

The three main classes of gonadal steroid hormones are:

1. Androgens: These are male sex hormones that are primarily produced by the testes but also produced in smaller amounts by the ovaries and adrenal glands. The most well-known androgen is testosterone, which plays a key role in the development of male secondary sexual characteristics such as facial hair, deepening of the voice, and increased muscle mass.
2. Estrogens: These are female sex hormones that are primarily produced by the ovaries but also produced in smaller amounts by the adrenal glands. The most well-known estrogen is estradiol, which plays a key role in the development of female secondary sexual characteristics such as breast development and the menstrual cycle.
3. Progestogens: These are hormones that are produced by the ovaries during the second half of the menstrual cycle and play a key role in preparing the uterus for pregnancy. The most well-known progestogen is progesterone, which also plays a role in maintaining pregnancy and regulating the menstrual cycle.

Gonadal steroid hormones can have significant effects on various physiological processes, including bone density, cognitive function, mood, and sexual behavior. Disorders of gonadal steroid hormone production or action can lead to a range of health problems, including infertility, osteoporosis, and sexual dysfunction.

"Papio" is a term used in the field of primatology, specifically for a genus of Old World monkeys known as baboons. It's not typically used in human or medical contexts. Baboons are large monkeys with robust bodies and distinctive dog-like faces. They are native to various parts of Africa and are known for their complex social structures and behaviors.

Mifepristone is a synthetic steroid that is used in the medical termination of pregnancy (also known as medication abortion or RU-486). It works by blocking the action of progesterone, a hormone necessary for maintaining pregnancy. Mifepristone is often used in combination with misoprostol to cause uterine contractions and expel the products of conception from the uterus.

It's also known as an antiprogestin or progesterone receptor modulator, which means it can bind to progesterone receptors in the body and block their activity. In addition to its use in pregnancy termination, mifepristone has been studied for its potential therapeutic uses in conditions such as Cushing's syndrome, endometriosis, uterine fibroids, and hormone-dependent cancers.

It is important to note that Mifepristone should be administered under the supervision of a licensed healthcare professional and it is not available over the counter. Also, it has some contraindications and potential side effects, so it's essential to have a consultation with a doctor before taking this medication.

The postpartum period refers to the time frame immediately following childbirth, typically defined as the first 6-12 weeks. During this time, significant physical and emotional changes occur as the body recovers from pregnancy and delivery. Hormone levels fluctuate dramatically, leading to various symptoms such as mood swings, fatigue, and breast engorgement. The reproductive system also undergoes significant changes, with the uterus returning to its pre-pregnancy size and shape, and the cervix closing.

It is essential to monitor physical and emotional health during this period, as complications such as postpartum depression, infection, or difficulty breastfeeding may arise. Regular check-ups with healthcare providers are recommended to ensure a healthy recovery and address any concerns. Additionally, proper rest, nutrition, and support from family and friends can help facilitate a smooth transition into this new phase of life.

Embryo implantation is the process by which a fertilized egg, or embryo, becomes attached to the wall of the uterus (endometrium) and begins to receive nutrients from the mother's blood supply. This process typically occurs about 6-10 days after fertilization and is a critical step in the establishment of a successful pregnancy.

During implantation, the embryo secretes enzymes that help it to burrow into the endometrium, while the endometrium responds by producing receptors for the embryo's enzymes and increasing blood flow to the area. The embryo then begins to grow and develop, eventually forming the placenta, which will provide nutrients and oxygen to the developing fetus throughout pregnancy.

Implantation is a complex process that requires precise timing and coordination between the embryo and the mother's body. Factors such as age, hormonal imbalances, and uterine abnormalities can affect implantation and increase the risk of miscarriage or difficulty becoming pregnant.

Luteinizing Hormone (LH) is a glycoprotein hormone, which is primarily produced and released by the anterior pituitary gland. In women, a surge of LH triggers ovulation, the release of an egg from the ovaries during the menstrual cycle. During pregnancy, LH stimulates the corpus luteum to produce progesterone. In men, LH stimulates the testes to produce testosterone. It plays a crucial role in sexual development, reproduction, and maintaining the reproductive system.

I apologize, but "estrenes" is not a term commonly used in medical terminology in English. It may be a term used in another language or context. If you could provide more context or clarify what you are looking for, I would be happy to help further.

Genital diseases in females refer to various medical conditions that affect the female reproductive system, including the vulva, vagina, cervix, uterus, and ovaries. These conditions can be caused by bacterial, viral, or fungal infections, hormonal imbalances, or structural abnormalities. Some common examples of genital diseases in females include bacterial vaginosis, yeast infections, sexually transmitted infections (STIs) such as chlamydia, gonorrhea, and human papillomavirus (HPV), pelvic inflammatory disease (PID), endometriosis, uterine fibroids, ovarian cysts, and vulvar or vaginal cancer. Symptoms of genital diseases in females can vary widely depending on the specific condition but may include abnormal vaginal discharge, pain or discomfort during sex, irregular menstrual bleeding, painful urination, and pelvic pain. It is important for women to receive regular gynecological care and screenings to detect and treat genital diseases early and prevent complications.

Premenopause is not a formal medical term, but it's often informally used to refer to the time period in a woman's life leading up to menopause. During this stage, which can last for several years, hormonal changes begin to occur in preparation for menopause. The ovaries start to produce less estrogen and progesterone, which can lead to various symptoms such as irregular periods, hot flashes, mood swings, and sleep disturbances. However, it's important to note that not all women will experience these symptoms.

The official medical term for the stage when a woman's period becomes irregular and less frequent, but hasn't stopped completely, is perimenopause. This stage typically lasts from two to eight years and ends with menopause, which is defined as the point when a woman has not had a period for 12 consecutive months. After menopause, women enter postmenopause.

Estrogens are a group of steroid hormones that are primarily responsible for the development and regulation of female sexual characteristics and reproductive functions. They are also present in lower levels in males. The main estrogen hormone is estradiol, which plays a key role in promoting the growth and development of the female reproductive system, including the uterus, fallopian tubes, and breasts. Estrogens also help regulate the menstrual cycle, maintain bone density, and have important effects on the cardiovascular system, skin, hair, and cognitive function.

Estrogens are produced primarily by the ovaries in women, but they can also be produced in smaller amounts by the adrenal glands and fat cells. In men, estrogens are produced from the conversion of testosterone, the primary male sex hormone, through a process called aromatization.

Estrogen levels vary throughout a woman's life, with higher levels during reproductive years and lower levels after menopause. Estrogen therapy is sometimes used to treat symptoms of menopause, such as hot flashes and vaginal dryness, or to prevent osteoporosis in postmenopausal women. However, estrogen therapy also carries risks, including an increased risk of certain cancers, blood clots, and stroke, so it is typically recommended only for women who have a high risk of these conditions.

Matrix metalloproteinase 3 (MMP-3), also known as stromelysin-1, is a member of the matrix metalloproteinase family. These are a group of enzymes involved in the degradation of the extracellular matrix, the network of proteins and other molecules that provides structural and biochemical support to surrounding cells. MMP-3 is secreted by various cell types, including fibroblasts, synovial cells, and chondrocytes, in response to inflammatory cytokines.

MMP-3 has the ability to degrade several extracellular matrix components, such as proteoglycans, laminin, fibronectin, and various types of collagen. It also plays a role in processing and activating other MMPs, thereby contributing to the overall breakdown of the extracellular matrix. This activity is crucial during processes like tissue remodeling, wound healing, and embryonic development; however, uncontrolled or excessive MMP-3 activation can lead to pathological conditions, including arthritis, cancer, and cardiovascular diseases.

In summary, Matrix metalloproteinase 3 (MMP-3) is a proteolytic enzyme involved in the degradation of the extracellular matrix and the activation of other MMPs. Its dysregulation has been implicated in several diseases.

Collagenases are a group of enzymes that have the ability to break down collagen, which is a structural protein found in connective tissues such as tendons, ligaments, and skin. Collagen is an important component of the extracellular matrix, providing strength and support to tissues throughout the body.

Collagenases are produced by various organisms, including bacteria, animals, and humans. In humans, collagenases play a crucial role in normal tissue remodeling and repair processes, such as wound healing and bone resorption. However, excessive or uncontrolled activity of collagenases can contribute to the development of various diseases, including arthritis, periodontitis, and cancer metastasis.

Bacterial collagenases are often used in research and medical applications for their ability to digest collagen quickly and efficiently. For example, they may be used to study the structure and function of collagen or to isolate cells from tissues. However, the clinical use of bacterial collagenases is limited due to concerns about their potential to cause tissue damage and inflammation.

Overall, collagenases are important enzymes that play a critical role in maintaining the health and integrity of connective tissues throughout the body.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

The word menstruation is etymologically related to moon. The terms menstruation and menses are derived from the Latin mensis ' ... Quotations related to Menstruation at Wikiquote Media related to Menstruation at Wikimedia Commons (CS1 maint: DOI inactive as ... Menstruation in mammals occurs in some close evolutionary relatives such as chimpanzees. Niddah (Jewish laws of menstruation) ... Many religions have menstruation-related traditions, for example: Islam prohibits sexual contact with women during menstruation ...
A menstruation celebration, first moon party, or period party, celebrates menstruation. Different cultures and communities ... In Assam, the menstruation celebration is called Toloni Biya/ Tuloni Biya/ Nua-tulon/Santi Biya. The word Biya in Assamese ... The age of menstruation onset is slightly younger for Black girls due to health disparities, increased material hardship, and ... Different states/regions and communities in India celebrate menstruation. The festival in Odisha is called Raja Parba or ...
The Páez people of the southwestern highlands of Colombia previously used menstruation huts. Menarche Culture and menstruation ... A menstruation hut is a place of seclusion or isolation used by certain cultures with strong menstrual taboos. The same or a ... During menstruation, a woman is not allowed to go in or across rivers, as her menstrual blood would render it ritually impure. ... If anyone were to come into contact with the woman during their menstruation, they too would have to stay in the hut. To avoid ...
This breakdown of the endometrium without vaginal discharge is sometimes called covert menstruation. Overt menstruation (where ... Overt menstruation (where there is bleeding from the uterus through the vagina) is found primarily in humans and close ... Menstruation is the shedding of the uterine lining (endometrium). It occurs on a regular basis in uninseminated sexually ... As these groups are not closely related, it is likely that four distinct evolutionary events have caused menstruation to arise ...
There is some concern that by focusing on menstruation as a focus in discussions in waste, it further stigmatizes menstruation ... Sustainable menstruation refers to the use of environmentally-friendly and responsible menstrual products. It is estimated that ... A sustainable approach to menstruation also attempts to tackle the issue of human rights and the dignity of manual scavengers. ... In India, 6% of non-biodegradable waste is created by hygiene products including menstruation products, wipes and diapers. The ...
Alternatively, a single menstruation cycle may be defined as irregular if it is less than 24 days or more than 38 days. If they ... Additionally, irregular menstruation is common in adolescence. A regular menstrual cycle can be set within a year of menarche. ... "Menstruation in Girls and Adolescents: Using the Menstrual Cycle as a Vital Sign". American College of Obstetricians and ... Irregular menstruation is a menstrual disorder whose manifestations include irregular cycle lengths as well as metrorrhagia ( ...
The ḥaiḍ (حيض menses) is the religious state of menstruation in Islam. The Qur'an makes specific mention of menstruation in ... Say, "It is harm, so keep away from wives during menstruation. And do not approach them until they are pure. And when they have ... This is written in verse 2:222 of the Quran And they ask you about menstruation. Say: It is a harm (painful situation); ... They do not have to make up the prayers they missed during menstruation. When the menstruating period is over, women have to ...
Hinduism's views on menstruation are diverse. Menstruation is seen as a period of purification, and women may or may not be ... Menstruation in synchrony with the moon is widely assumed in myths and traditions as a ritual ideal. The idea that menstruation ... Menstruation and the power of Yurok women. In T. Buckley and A. Gottlieb (eds), Blood Magic. The anthropology of menstruation. ... The essay "Menstruation in Fiction" in the 2022 book Period Matters: Menstruation in South Asia examines the male and female ...
... less specific than Jewish male menstruation, with Freud having claimed to experience male menstruation himself. In the era of ... Jewish male menstruation is the belief that Cisgender Jewish men experience menstrual periods, or periodic bleeding. This ... A very similar explanation for why Jewish men supposedly menstruated has to do with the idea that menstruation is a 'curse.' ... In this work, Fritsch argued for the antisemitic claim that male menstruation was a sign that Jewish people had a different ...
The period before menstruation, known as the premenstrual phase, is often linked to emotional distress. Conditions related to ... Menstruation is linked to a range of psychopathological symptoms, such as lower self-esteem, increased anxiety, dysphoria, and ... Menstruation involves hormonal fluctuations and physiological changes in the body, which can affect a person's mood and ... Menstruation can have a notable impact on mental health, with some individuals experiencing mood disturbances and ...
... at IMDb The Story of Menstruation at Rotten Tomatoes The Story of Menstruation at Disney A to Z ( ... The Story of Menstruation is believed to be the first film to use the word "vagina" in its screenplay. Sexuality is not ... The Story of Menstruation increased its reputation when it received the Good Housekeeping Seal of Approval. It was one of the ... The Story of Menstruation is a 1946 10-minute American animated film produced by Walt Disney Productions. It was commissioned ...
... and sweating were viewed similarly to menstruation, and were even considered to be a form of vicarious menstruation. As a ... but there were different understandings of what menstruation might be caused by. The two main beliefs surrounding menstruation ... Many beliefs amount menstruation in the early modern period were linked to humorism, the system of medicine introduced by ... This text can be used as an example of the disgust towards menstruation that may have been found at the time: Press not your ...
Menstruation and the origins of culture. New Haven and London: Yale University Press, pp. 417-513. Warner, W. L. 1957. A Black ... Menstruation and the origins of culture. New Haven and London: Yale University Press, pp. 449-479. Jones, David E. (2000), An ... Blood Relations: Menstruation and the Origins of Culture is a book by the evolutionary anthropologist Chris Knight. Published ... Blood Relations: Menstruation and the origins of culture. Marek Kohn, 'Survival of the Chattiest.' Independent on Sunday, 4 ...
"Menstruation." In In the Image of God: A Feminist Commentary on the Torah, pages 276-87. Northvale, New Jersey: Jason Aronson, ... "In Rural Nepal, Menstruation Taboo Claims Another Victim." The New York Times. January 11, 2018, page A4. Masoretic text and ... Rabbi Meir taught that the Torah ordained that menstruation should separate a wife from her husband for seven days, because if ... Elaine Goodfriend argued that the regulations of menstruation in Leviticus 15:19-24 probably had a smaller practical impact on ...
"Menstruation". La Leche League International. Retrieved 15 November 2021. "Breastfeeding, Family Physicians Supporting ( ... Breastfeeding delays the return of menstruation, and in very specific circumstances, fertility, a phenomenon known as ...
Menstruation. OCLC Online Computer Library Center, Inc. OCLC 13596472. Richard Chichester Mason. "... Menstruation". Franklin: ... Mason's doctoral thesis was on menstruation. Shortly before this boy's birth, his father Thomson Mason inherited a portion of ...
... menstruation; neck injury; pregnancy; and shoulder injury. The practice of asanas has sometimes been advised against during ...
Menstruation and the origins of culture. New Haven and London: Yale University Press, pp. 122-153. ISBN 0-300-04911-0 Power, C ... Menstruation and the origins of culture. New Haven and London: Yale University Press, pp. 122-153. ISBN 0-300-04911-0 Power, C ... Menstruation and the origins of culture. New Haven and London: Yale University Press. Watts, I. M. Chazan; Wilkins, J. (2016 ... Menstruation has little social impact among chimpanzees or bonobos, since visible oestrus swellings are the focus of male ...
This was incorrectly attributed[by whom?] to menstruation.[citation needed]. Eileen McNamara's. At the 1996 Olympic Games, she ...
Some large-scale paintings with openly Neo-Expressionist brushwork have survived from that time (e.g. Menstruation, 1989; ...
... and menstruation. Malnutrition can lead to vitamin and other deficiencies and to inactivity, which in turn may pre-dispose to ...
"Next big thing, why condom size matters". Menstruation.com. 2007-10-11. Archived from the original on 2008-10-18. Retrieved ...
Menstruation Bathroom - by Judy Chicago. The bathroom is painted a stark white, and a layer of gauze covers the shelves. A ... Rooms included a pink kitchen, a bride thrown against a wall, a closet with sheets, and a bathroom for menstruation. Nurturant ... "Menstruation Bathroom." Art Journal 31, no. 3: 269. Chicago, Judy and Miriam Schapiro. 1971. "Feminist Art Program." Art ... Menstruation Bathroom, Cock and Cunt Play) Susan Frazier (Nurturant Kitchen/Aprons in Kitchen) Camille Grey (Lipstick Bathroom ...
Judaism portal Culture and menstruation Jewish views on marriage Menstruation hut Mikveh Calendar Negiah (guidelines for ... as her previous menstruation began; the day exactly 30 days after the previous menstruation started; and the day that is of ... whether it is due to menstruation, childbirth, sexually transmitted disease, or other reasons. If menstruation began before she ... women and menstruation. Later on, the rabbis increased the period of sexual separation between a menstruating wife and her ...
... a patient to health was modeled on the process of menstruation. Hippocrates believed that menstruation functioned to "purge ... Bloodletting was even used to treat most forms of hemorrhaging such as nosebleed, excessive menstruation, or hemorrhoidal ... Coutinho, Elsimar M. (1999). Is Menstruation Obsolete?. Oxford University Press. ISBN 0-19-513021-9. Western medical thought ...
Urquiola's March 1829 dissertation Urquiola, Joseph M. (1829). "Essay on Menstruation". Penn Libraries Franklin. was cited in ...
... some stimulate menstruation. Women use emmenagogues to stimulate menstrual flow when menstruation is absent for reasons other ... In Haiti and Jamaica sage is taken to stimulate menstruation. The technical term for such an agent is emmenagogue. "LiverTox: ... these herbs were also used to assist women whose menstruation was "delayed", for the reason that they had conceived. There are ...
His book Is Menstruation Obsolete?, co-authored with Sheldon Segal in 1996, is in its 8th edition. The English version of this ... Those studies culminated in the publishing of "Is Menstruation Obsolete", co-authored with Sheldon Segal. O Sexo do Ciúme ... Coutinho, Elsimar M; Segal, Sheldon J; Coutinho, Elsimar M (1999). Is menstruation obsolete?. New York: Oxford University Press ...
Patterns of menstruation are examined since irregular patterns may accompany hyperandrogenism. Other conditions that may ... Patient history assessed includes age at thelarche, adrenarche, and menarche; patterns of menstruation; obesity; reproductive ... irregularities in menstruation, clitoral hypertrophy, and the deepening of the voice. Drugs most frequently implicated in ... and infrequent or absent menstruation. Complications may include high blood cholesterol and diabetes. It occurs in ...
"Report of Gilbreth, Inc.: The perfect menstrual pad, January 1, 1927". Museum of Menstruation. Retrieved April 16, 2011. Graham ...
The word menstruation is etymologically related to moon. The terms menstruation and menses are derived from the Latin mensis ... Quotations related to Menstruation at Wikiquote Media related to Menstruation at Wikimedia Commons (CS1 maint: DOI inactive as ... Menstruation in mammals occurs in some close evolutionary relatives such as chimpanzees. Niddah (Jewish laws of menstruation) ... Many religions have menstruation-related traditions, for example: Islam prohibits sexual contact with women during menstruation ...
Menstruation (or period) happens monthly. As the uterus sheds its lining, vaginal bleeding follows. Menstrual blood is made of ... About Menstruation (Eunice Kennedy Shriver National Institute of Child Health and Human Development) Also in Spanish ... Menstruation, or period, is normal vaginal bleeding that occurs as part of a womans monthly cycle. Every month, your body ... The primary NIH organization for research on Menstruation is the Eunice Kennedy Shriver National Institute of Child Health and ...
Tag: menstruation. The Museum of Menstruation. July 18, 2017. Marc Abrahams If you are, or ever have been, or ever might be ... Arts and Sciencemenstruation, museum Menstruation music videos for kids. October 17, 2015. Marc Abrahams ... Arts and Science, Boys Will Be Boysmenstruation, music video Bloody, difficult to believe: Menstruation by the Ear. November 24 ... This is one of the few medically documented claims of ear menstruation: "Menstruation by the Ear, " New York Medical Journal, ...
Menstruation news - latest news direct from companies - read online or subscribe to feed or by email - press releases - By Tag ... Menstruation Press Releases. Exclusive News. Topics Locations Industries Dates. Hekate N.Z. Guides Women with P.C.O.S. to a ...
Observational data suggest that menstruation can alter A1c readings and that the cut-off value for diagnosis of type 2 diabetes ... Cite this: Menstruation Linked to Underdiagnosis of Type 2 Diabetes? - Medscape - Oct 02, 2023. ...
Menstruation is painful, socially awkward, quite expensive and most of the time very problematic to manage for the girls and ... Menstruation is painful, socially awkward, quite expensive and most of the time very problematic to manage for the girls and ... Secondly, the lack of access to safe toilets with cleans water, soap and baskets where she can manage her menstruation with ... Thus, when 41% of the school going girls in Bangladesh do not attend classes during their menstruation and 73% women miss their ...
... looks to take the stigma out of menstruation and menopause. ... Periodical aims to de-stigmatize menstruation and menopause. ... The new documentary film Periodical looks to take the stigma out of menstruation and menopause.Nov. 17, 2023 ...
... disorders of menstruation may present as abnormal uterine bleeding (AUB). Broadly understood, this term includes absence of ... encoded search term (Menstruation Disorders in Adolescents) and Menstruation Disorders in Adolescents What to Read Next on ... To determine what constitutes a disorder of menstruation, one must first have a clear understanding of normal menstruation. ... Menstruation Disorders in Adolescents. Updated: May 08, 2023 * Author: Kirsten J Sasaki, MD, FACOG; Chief Editor: Andrea L ...
Menstruation, or a period, is when the lining of the uterus sheds and leaves the body as blood. It marks the beginning of a ... Menstruation is when the lining of the uterus sheds, causing blood to flow from the vagina. Usually, it lasts around 3-7 days. ... Menstruation stops when someone is pregnant, so having a period means a person is not pregnant. It also marks the beginning of ... Menstruation occurs when the lining of the uterus sheds, turning into blood. This blood then flows out of the body through the ...
"What is Menstruation? This explains the rough physiology; here is a cup showing roughly the average amount of blood lost by a ... January 1999: The Museum of Menstruation (MUM) has closed the doors of its New Carrollton, MD, facility, and can now only be ... This is quite understandable, since were looking for the Museum of Menstruation. ... a combination of goodies which will help assuage the pains and discomforts of menstruation." Another wall features drawings and ...
MENstruation, Annual ID: OS_BE20_039M, Award: Merit Award, Category: Branded Entertainment - Short Form Video / Single ...
Get all of the latest Menstruation news from Yorkshire Evening Post. Providing a fresh perspective for online news. ... Get all of the latest Menstruation news from Yorkshire Evening Post. Providing a fresh perspective for online news. ...
10 things girls need to know about menstruation. 1. Its normal. Menstruation is a normal process that should happen to every ... 6. Sometimes menstruation can be painful! The amount of pain can differ a lot from girl to girl and from month to month. Most ... 2. Menstruation is not a sickness. Girls can live their normal life during menses - they can go to school, play with their ... 5. Menstruation does not have to be a secret. There is a big difference between being discreet and keeping something secret ...
The mission of the Media Research Center is to document and combat the falsehoods and censorship of the news media, entertainment media and Big Tech in order to defend and preserve Americas founding principles and Judeo-Christian values. The MRC is a research and education organization operating under Section 501(c)(3) of the Internal Revenue Code, and contributions to the MRC are tax-deductible.. ...
Breaking Menstruation Taboos and Leaving No Girl Behind. By Joyce Chimbi Reprint , , Print , ... clubs which are helping break the silence around the issue of menstruation. Targeted girls learn about menstruation, start to ... Menstruation used to prevent her from going to school.. "Before the JRS menstrual hygiene management kit, I had nothing to wear ... "The initiative seeks to break the taboo around menstruation in schools. We have come a long way. Teachers are talking about ...
MD talks about the inspiration behind her animated menstrual cycle exhibit and hopes to destigmatize menstruation. Read her Q&A ... Q. How can I watch the menstruation animation?. You can watch the animation on the Mahalingaiah Lab YouTube page. It is a ... I am inspired by my students and their questions, and their desire to learn more about the complex process of menstruation. I ... Q. Why do you think menstruation is cloaked in stigma and misunderstanding?. This question is important; there are many reasons ...
Tags: Menstrual Cycle Mapping, Estrogen, Progesterone, Saliva Testing, Blood Spot Testing, Menstruation ... Historically a taboo subject, menstruation has long been stigmatized as unclean and negative; provoking multiple complex ... we know so much more about the biochemical basics and physical aspects of menstruation. We are now also beginning to better ...
Gone are the days when menstruation, one of our countrys major taboos, was spoken with a hush or a shh in our society. ... can assist to reduce the stigma associated with menstruation. Sustainable menstruation will be the subject of a private-public ... Access to hygienic menstruation products has become a faraway dream for women from low-income families. Reusable items, such as ... Gone are the days when menstruation, one of our countrys major taboos, was spoken with a hush or a shh in our society. ...
Menstruation A Cultural History ... http//us.macmillan.com/menstruation ... Blood Relations Menstruation and the Origins of ... Menstruation. Menstruation is the shedding of the uterine lining (endometrium). It occurs on a regular basis at a very young ... Menstruation And The Origins Of Culture/Archive 1. ... The relationship between culture and menstruation is expressed in many ... Famous quotes containing the word menstruation:. "If men could menstruate ... clearly, menstruation would become an enviable, ...
As a woman, I would have to agree, menstruation is normal. While I experience this normal event every month, most of the time ... Here is the deal: menstruation is normal and latrines are a front-line response to this fact. Girls and women need private ... We need to help communities and families make the provisions so that girls will really believe that menstruation is normal - ... Menstruation is Normal. As part of a WASH campaign, the other buildings had other messages - about handwashing and drinking ...
Tag Archive for: menstruation. Can Menstruating Women Go to the Masjid for Islamic Courses?. September 20, 2023. ... Is My Calculation of Menstruation Correct?. August 29, 2023. Answered by Mawlana Ilyas Patel Question I am trying to identify… ... Is My Prolonged Bleeding Menstruation or Irregular Bleeding?. July 9, 2023. Answered by Mawlana Ilyas Patel Question I have my ... 06Is My Calculation of Menstruation Correct?. How Do I Perform My Missed Prayers and Current Prayers in a State of Irregular ...
Free Being Me and Stop The Violence built my knowledge and led me to start talking about menstruation and share the better ways ... Menstruation shouldnt restrict our options - Introducing the Freedom Kit bag * Europe Region discusses the impact of Covid-19 ... Menstruation shouldnt restrict our options - Introducing the Freedom Kit bag. Nirmala, a Girl Scout from Nepal, grew up in ... I come from a family where a girl is not allowed to go to kitchen, worship God, or water any plants during menstruation. This ...
The thing is, we need to talk about menstruation more, not less. We need to normalise conversations surrounding periods and ... The state legislature in Florida has passed a law restricting information about menstruation in schools to student in sixth ... These efforts reduce the stigma surrounding menstruation and remove barriers to care that hold back entire nations. ... Casting menstruation as a taboo is dangerous. .css-1wt8oh6{font-family:"Georgia","Times","Times New Roman",serif;}. While India ...
A basic human function like menstruation should no longer be a justification for denying women and girls with disabilities ... End the Stigma: Why Menstruation Matters to Womens Rights. A basic human function like menstruation should no longer be a ... Dropping out of school is not the only life-altering consequence of the stigma surrounding the menstruation cycle of women and ... A basic human function like menstruation should no longer be a justification for denying women and girls with disabilities ...
Menstruation and magick: Reclaiming the power of the body. Chrysanthemum White Alder - 13 December 2017. 0 ...
Menstruation Cycle. June 4, 2022. Dr. Meenakshi Chauhan Cheat Meals During Menstruation Cycle - Good Or Bad Is It Ok To Have ... Cheat Meals During The Menstruation Cycle To Fulfill Cravings You would be following a diet plan and trying to eat healthy and ...
History period - a look at menstruation through the ages in 15 fascinating facts. Comment ... Other menstruation myths and misunderstandings also persisted, some of which are still alive today. ... So its time for history period - a look at menstruation through the ages in 15 fascinating facts. ...
A study published Friday in Science Advances reported that 42% of respondents had heavier cycles after receiving the COVID-19 vaccine.
Blood stains on clothing from menstruation is a frustration for many. Heres how you should approach stain removal without ...
So here comes again the next month when you women out there begin to feel dizzy, lethargic and absolutely dull. Whats new? This ...

No FAQ available that match "menstruation"

No images available that match "menstruation"